RecruitingPhase 4ACTRN12623000825651

The Effect of Volatile Versus Total Intravenous Anaesthesia (TIVA) on the Inducibility of Tachyarrhythmias During Ventricluar Tachycardia (VT) Ablation Procedures

The Effect of Volatile Versus Total Intravenous Anaesthesia on the Inducibility of Tachyarrhythmias During Ventricular Tachycardia Ablation procedures


Sponsor

Departments of Anaesthesia, Cardiology - Westmead Hospital

Enrollment

24 participants

Start Date

Jun 1, 2023

Study Type

Interventional

Conditions

Summary

This is a pilot RCT to test the hypothesis that sevoflurane use for maintenance of general anaesthesia will result in reduced inducibility of ventricular tachyarrhythmias when compared to maintenance with propofol. The study is conducted in adult patients (>18 years) who are scheduled for elective or semi- elective ventricular tachycardia ablation under general anaesthesia at 2 hospitals in Sydney. Patients will receive both types of anaesthesia for maintenance during 2 subsequent periods of time (in random order, and with a wash-out period in between). During each period, a standardised VT induction protocol will be performed. The primary outcome of the study is VT inducibility. Secondary outcomes include modes of induction required, quality of recovery on post-procedure day 1, and long-term ablation success rate.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

Ventricular tachycardia (VT) is a dangerous fast heart rhythm that originates in the lower chambers of the heart. To treat it, doctors can perform a procedure called VT ablation, which uses heat energy to destroy the tiny areas of heart tissue causing the abnormal rhythm. This is usually done under general anaesthesia. This study is investigating whether the type of anaesthetic gas used during the procedure affects how easily VT can be triggered during the ablation, because triggering VT on purpose is an important part of the procedure to locate the abnormal tissue. Participants will receive both types of anaesthesia — a gas-based anaesthetic (sevoflurane) and an intravenous anaesthetic (propofol) — at different points during the same procedure, in random order. Researchers will compare how easily VT is triggered under each type of anaesthesia, as well as recovery quality and long-term ablation success. You may be eligible if you are 18 or older, are scheduled for an elective or semi-elective VT ablation procedure under general anaesthesia at one of two participating Sydney hospitals, and are medically fit for general anaesthesia. Patients who are haemodynamically unstable before the procedure are not eligible.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Volatile group: Continuous inhaled sevoflurane (titrated to adequate end-tidal concentrations) for maintenance of general anaesthesia for at least the duration of the VT induction (5-10 minutes). Age-

Volatile group: Continuous inhaled sevoflurane (titrated to adequate end-tidal concentrations) for maintenance of general anaesthesia for at least the duration of the VT induction (5-10 minutes). Age-based MAC values >0.6 will generally be considered adequate. However, the required level will be titrated based on processed EEG-monitoring. TIVA group: Continuous intravenous propofol (using a target-controlled infusion protocol) for maintenance of general anaesthesia for at least the duration of the VT induction. Using a pre-programmed Schnider model, propofol infusion will generally be aiming for an effect site concentration between 2 and 5 mcg/ml. The required level will be titrated based on processed EEG-monitoring. As part of the cross-over design, patients will be switched from one type of medication to the other during the procedure, after the first VT induction. There will be a 30-minute wash out period in between. At least one of the maintenance medication will be continuously administered at any point in time to keep the patient anaesthetised. MAC values, infusion rates and processed EEG values (BIS) will be collected during the VT inductions. The total duration of the measurements (including wash out) will be around 45 minutes. The duration of the entire general anaesthetic depends on the duration of the VT ablation procedure, but typically varies between 2 and 6 hours.


Locations(2)

Westmead Hospital - Westmead

NSW, Australia

Westmead Private Hospital - Westmead

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12623000825651


Related Trials